Heart, Lung and Circulation
Volume 16, Issue 1 , Pages 10-15 , February 2007

The Mystery of Coronary Artery Spasm

  • Andrew E. Ajani, MD, FRACP, FJFICM, FCSANZ

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
    • National Health Medical Research Council, Centre of Clinical Research Excellence in Therapeutics Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Royal Melbourne Hospital, Grattan Street, Parkville 3050, Australia. Tel.: +61 3 9347 0499; fax: +61 3 9347 6760.
    • ,
  • Bryan P. Yan, FRACP

      Affiliations

    • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia

Reference 

  1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959;27:375–388
  2. Konidala S, Gutterman DD. Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovasc Dis. 2004;46(4):349–373
  3. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65(7):1299–1306
  4. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23(4):833–843
  5. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 1996;94(3):266–271
  6. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87(1):76–79
  7. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation. 1989;80(6):1617–1626
  8. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol. 1989;63(1):17–20
  9. Fuller CM, Raizner AE, Chahine RA, Nahormek P, Ishimori T, Verani M, et al. Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. Am J Cardiol. 1980;46(3):500–506
  10. Miwa K, Kambara H, Kawai C, Murakami T. Two electrocardiographic patterns with or without transient T-wave inversion during recovery periods of variant anginal attacks. Jpn Circ J. 1983;47(12):1415–1422
  11. Previtali M, Klersy C, Salerno JA, Chimienti M, Panciroli C, Marangoni E, et al. Ventricular tachyarrhythmias in Prinzmetal's variant angina: clinical significance and relation to the degree and time course of S-T segment elevation. Am J Cardiol. 1983;52(1):19–25
  12. Miller DD, Waters DD, Szlachcic J, Theroux P. Clinical characteristics associated with sudden death in patients with variant angina. Circulation. 1982;66(3):588–592
  13. Suzuki M, Nishizaki M, Arita M, Ashikaga T, Yamawake N, Kakuta T, et al. Increased QT dispersion in patients with vasospastic angina. Circulation. 1998;98(5):435–440
  14. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999;33(6):1442–1452
  15. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation. 2000;101(10):1102–1108
  16. Baba S, Ozawa H, Sakai Y, Terao A, Konishi M, Tatara K. Heart disease deaths in a Japanese urban area evaluated by clinical and police records. Circulation. 1994;89(1):109–115
  17. Kawano H, Ogawa H. Endothelial function and coronary spastic angina. Intern Med. 2005;44(2):91–99
  18. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther. 1994;8(4):601–610
  19. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996;27(6):1444–1449
  20. Kugiyama K, Murohara T, Yasue H, Kimura T, Sakaino N, Ohgushi M, et al. Increased constrictor response to acetylcholine of the isolated coronary arteries from patients with variant angina. Int J Cardiol. 1995;52(3):223–233
  21. Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest. 1992;89(3):1047–1052
  22. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, et al. Links Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996;27(6):1444–1449
  23. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372(6503):231–236
  24. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999;43(4):1029–1039
  25. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1 beta. Circulation. 2000;101(11):1319–1323
  26. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105(13):1545–1547
  27. Pollock DM, Pollock JS. Endothelin and oxidative stress in the vascular system. Curr Vasc Pharmacol. 2005;3(4):365–367
  28. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840–844
  29. Matsubara T, Nakazawa M, Yoshida Y, Imai S, Suzuki K, Hori T, et al. Increasing vasoconstrictor response to ergonovine with oxidative injury in canine coronary artery. Coron Artery Dis. 1997;8(1):1–7
  30. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266(3 Pt 2):H874–H880
  31. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332(18):1198–1203
  32. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87(1):76–79
  33. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998;32(6):1672–1679
  34. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, et al. Improvement of endothelial function and insulin sensitivity with Vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol. 2000;35(7):1860–1866
  35. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol. 1999;83(8):1186–1190
  36. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation. 1974;50(3):534–539
  37. Bertrand ME, Lablanche JM, Tilmant PY, Ducloux G, Warembourg H, Soots G. Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol. 1981;47(6):1375–1378
  38. Winniford MD, Filipchuk N, Hillis LD. Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation. 1983;67(6):1185–1188
  39. Robertson RM, Bernard YD, Carr RK, Robertson D. Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha 1-receptor blockade with prazosin. J Am Coll Cardiol. 1983;2(6):1146–1150
  40. Chang K, Baek SH, Seung KB, Kim PJ, Ihm SH, Chae JS, et al. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis. 2003;14(4):293–299
  41. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants. J Investig Med. 2000;48(5):367–374
  42. Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet. 2002;110(1):89–94
  43. Horimoto M, Wakisaka A, Takenaka T, Igarashi K, Inoue H, Yoshimura H, et al. Familial evidence of vasospastic angina and possible involvement of HLA-DR2 in susceptibility to coronary spasm. Jpn Circ J. 1998;62(4):284–288
  44. Nakao K, Ohgushi M, Yoshimura M, Morooka K, Okumura K, Ogawa H, et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol. 1997;80(5):545–549
  45. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis. 2004;15(8):491–497
  46. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation. 1986;74(6):1255–1265
  47. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33(6):1756–1824
  48. Sueda S, Izoe Y, Kohno H, Fukuda H, Uraoka T. Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan. Circ J. 2005;69(11):1333–1337
  49. Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol. 1980;46(2):329–334
  50. Sueda S, Saeki H, Otani T, Mineoi K, Kondou T, Yano K, et al. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. Am J Cardiol. 2000;85(3):391–394
  51. Adlam D, Azeem T, Ali T, Gershlick A. Is there a role for provocation testing to diagnose coronary artery spasm?. Int J Cardiol. 2005;102(1):1–7
  52. Hamilton KK, Pepine CJ. A renaissance of provocative testing for coronary spasm?. J Am Coll Cardiol. 2000;35(7):1857–1859
  53. Miwa K, Fujita M, Miyagi Y. Beneficial effects of smoking cessation on the short-term prognosis for variant angina—validation of the smoking status by urinary cotinine measurements. Int J Cardiol. 1994;44(2):151–156
  54. Freedman SB, Richmond DR, Kelly DT. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am J Cardiol. 1982;50(4):711–715
  55. Ardissino D, Savonitto S, Mussini A, Zanini P, Rolla A, Barberis P, et al. Felodipine (once daily) versus nifedipine (four times daily) for Prinzmetal's angina pectoris. Am J Cardiol. 1991;68(17):1587–1592
  56. Satake K, Lee JD, Shimizu H, Ueda T, Nakamura T. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. J Am Coll Cardiol. 1996;28(4):897–902
  57. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation. 1989;79(3):597–602
  58. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol. 2002;90(9):974–982
  59. Sueda S, Kohno H, Fukuda H, Watanabe K, Ochi N, Kawada H, et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest. 2003;123(2):380–386
  60. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J. 1996;17(7):1015–1021
  61. Khatri S, Webb JG, Carere RG, Dodek A. Stenting for coronary artery spasm. Catheter Cardiovasc Interv. 2002;56(1):16–20
  62. Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Crea F, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol. 1999;84(1):96–98
  63. Tanabe Y, Itoh E, Suzuki K, Ito M, Hosaka Y, Nakagawa I, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol. 2002;39(7):1120–1126
  64. Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982;65(2):281–285
  65. Turlapaty PD, Altura BM. Propranolol induces contractions of canine small and large coronary arteries. Basic Res Cardiol. 1982;77(1):68–81
  66. Tilmant PY, Lablanche JM, Thieuleux FA, Dupuis BA, Bertrand ME. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol. 1983;52(3):230–233
  67. Miwa K, Kambara H, Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J. 1983;105(2):351–355
  68. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988;78(1):1–9
  69. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Theroux P. Long-term prognosis of patients with variant angina. Circulation. 1987;76(5):990–997
  70. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol. 1988;18(3):331–349
  71. Pasceri V, Lanza GA, Patti G, Pedrotti P, Crea F, Maseri A. Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina. Circulation. 1996;94(8):1850–1856
  72. Friedman AC, Spindola-Franco H, Nivatpumin T. Coronary spasm: Prinzmetal's variant angina versus catheter-induced spasm; refractory spasm versus fixed stenosis. AJR Am J Roentgenol. 1979;132(6):897–904
  73. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Circulation. 1988;78(6):1323–1334
  74. Moukarbel GV, Dakik HA. Diffuse coronary artery spasm induced by guidewire insertion. J Invasive Cardiol. 2003;15(6):353–354
  75. Gruberg L, Waksman R. Severe acute coronary spasm following intracoronary radiation for in-stent restenosis: a case report. Cardiovasc Radiat Med. 2001;2(3):138–142
  76. el-Tamimi H, Davies GJ, Crea F, Maseri A. Response of human coronary arteries to acetylcholine after injury by coronary angioplasty. J Am Coll Cardiol. 1993;21(5):1152–1157
  77. Lange RA, Cigarroa RG, Yancy CW, Willard JE, Popma JJ, Sills MN, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321(23):1557–1562
  78. Mo W, Singh AK, Arruda JA, Dunea G. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens. 1998;11(6 Pt 1):708–714
  79. Nakamura Y, Shinozaki N, Hirasawa M, Kato R, Shiraishi K, Kida H, et al. Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J. 2000;64(4):239–242
  80. Murakami H, Hirokami M, Hanawa N, Oomoto Y, Yamaguchi Y, Miyamoto K, et al. Acetylcholine-induced coronary spasm with a history of Kawasaki disease: case report. Circ J. 2003;67(3):273–274
  81. Petrakopoulou P, Franz WM, Boekstegers P, Weis M. Vasospastic angina pectoris associated with Churg-Strauss syndrome. Nat Clin Pract Cardiovasc Med. 2005;2(9):484–489

PII: S1443-9506(06)00279-4

doi: 10.1016/j.hlc.2006.11.003

Heart, Lung and Circulation
Volume 16, Issue 1 , Pages 10-15 , February 2007

Article Tools